| abstract |
The present invention provides compounds of formula (I): n n n n n n n n n n compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated); and methods of treating patients with such compounds; wherein R 1 to R 9 are as defined herein. |